# Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck

> **NCT02201355** · PHASE1 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck T1/2N0-2

## Interventions

- **RADIATION:** Intensity Modulated Radiotherapy

## Key facts

- **NCT ID:** NCT02201355
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09-18
- **Primary completion:** 2018-01-23
- **Final completion:** 2020-05-15
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** PI LEFT THE DEPARTMENT
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201355, "Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02201355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*